Navigation Links
Jubilant Enters Research Collaboration With AstraZeneca
Date:5/5/2009

ation complements our internal capabilities and increases the capacity of our pre-clinical programs. It is a concrete example of the innovative approaches we are taking to deliver a sustainable Discovery pipeline with a lean and agile organization. Ultimately, this will provide us with more shots on goal as we look to sustain a competitive portfolio and provide meaningful medicines to patients."

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. For more information about AstraZeneca, please visit: http://www.astrazeneca.com

About Jubilant Biosys

Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd.,provides integrated drug discovery and development solutions to the global pharmaceutical industry. Jubilant Biosys has an integrated state of the art facility in Bangalore. The Center houses over 300 scientists specializing in multiple disciplines to include Discovery biology, medicinal chemistry, structural biology, pharmacology, toxicology, pharma chem, molecular modeling, crystallography and information technology supporting discovery efforts.

For more information please visit: http://www.jubilantbiosys.com

About Jubilant Organosys

Jubilant Organosys Ltd. is an integrated pharmaceutical industry player, one of the largest custom research and manufacturing services (CRAMS) and drug discovery and development services companies out of India. The
'/>"/>

SOURCE Jubilant Organosys Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds
2. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
3. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
4. Another LNA-based RNA Inhibitor Enters Clinical Trials
5. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
6. ESBATechs Antibody Fragment Enters Phase Ib/IIa in Ophthalmology
7. ESBATechs Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity
8. ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
9. PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
10. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
11. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... an opportune time to find the best plan at ... 15 Through the end of the year, ... decisions about their health coverage. This is when ... health benefits they will sign up and pay for ... critical part of this decision, says Independent Retail Pharmacist ...
(Date:12/15/2009)... Fenwal Inc., a global medical technology company focused ... announced today that the U.S. Food and Drug ... ® platelet additive solution. Fenwal ® ... product used in combination with human plasma to ... to prevent or treat bleeding. ,, InterSol ® ...
(Date:12/15/2009)... ,, Reportlinker.com announces that a new market ... ,, Hepatitis B Vaccines - Pipeline ... ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Hepatitis B ... to 2015 ,, Summary ,, ... "Hepatitis B Vaccines - Pipeline Analysis and ...
Breaking Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Eric Pettigrew to Lead Regences Community and Business Relations Efforts 52705 1Eric Pettigrew to Lead Regences Community and Business Relations Efforts 52705 2Coming Soon Stem Cell Surgical Thread 3F 52701 1Coming Soon Stem Cell Surgical Thread 3F 52701 2DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 1DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 2DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 3DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 4DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 5DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 6DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 7DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 8DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 9DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 10DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 11DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 12DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 13DOE funded research projects win 46 R 26amp 3BD 100 Awards for 2009 9355 14
... Patients Nearly Triple That,of General Population, Affecting ... 2007 /PRNewswire-FirstCall/ -- Data from a,recent clinical ... Attention- Deficit/Hyperactivity Disorder,(ADHD) in patients with comorbid ... safely and effectively with Strattera in,patients with ...
... Co, Ltd. Sponsored Study,Presented at the American ... May 23, 2007 /PRNewswire/ -- In a ... with schizophrenia, the Otsuka,Pharmaceutical Co., Ltd. and ... improvement,compared to placebo on the primary efficacy ...
Other Medicine Technology:Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9
(Date:12/16/2009)... Just in time for the Christmas rush Hallmark Cards have announced ... services in the industry. With an easy to navigate website at ... invite or thank you with their own words and photos and ... Multibuy option. , ... Bradford, UK (PRWEB) December 16, ...
(Date:12/16/2009)... Foods will be carrying Dr. Shapio,s Help Hair Shake in all of ... ... (PRWEB) December 16, 2009 -- Dr. Larry Shapiro, hair transplant ... Foods stores will be carrying the Help Hair Whey Protein Shake. ... suitable as an adjunct for weight loss programs, working out and muscle ...
(Date:12/15/2009)... WASHINGTON, Dec. 15 The failure of ... drugs to cut costs, much less the more ... just the latest example of how big industry ... ,, "The proposed drug amendment by Senator Dorgan ... President Obama,s campaign pledge to allow Medicare to ...
(Date:12/15/2009)... Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the ... that shareholders had approved all three resolutions that the Company had proposed at the Annual ... , Description of ... Votes Non-, ... For ...
(Date:12/15/2009)... Senator earns lump of coal for lying about taxes in ... -- Sen. Max Baucus has earned a place under the ... and Nice List after being caught telling a brazen ... that the Senate healthcare bill would not raise taxes. ... Baucus said: ,, " I ...
Breaking Medicine News(10 mins):Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 3Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 4Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3
... team-based care do not save more in treatment ... but they are healthier, according to a recent ... burden on patients, payers and employers," said Dennis ... State, and lead author of the study. "Assessing ...
... Feb. 26, 2009 Arthritis affects more than half ... a substantial barrier to utilizing physical activity to help ... and Mortality Weekly Report ( MMWR ) study ... Prevention (CDC). According to the Arthritis Foundation, the study ...
... ─ It,s a honey of a garden, the judges ... series of interconnected gardens with such names as "Honeycomb ... international bee-friendly garden design competition, a gift to the ... , The design, the work of landscape architects Donald ...
... an ingredient in sunscreen, researchers say , , THURSDAY, Feb. 26 ... offer some protection from skin cancer, and new research may ... be the mechanism by which caffeine is associated with decreased ... professor of dermatology at the University of Washington in Seattle. ...
... 2008 MVP Albert Pujols support nationwide programCHICAGO, Feb. ... annual Give Kids A Smile(R) program provided free ... across the country. Enrolled through their schools, ... received X-rays, fillings, cleanings, sealants, educational materials, ...
... Must Reform Ineffective 33-year-old Chemicals Law, Expert Testifies WASHINGTON, ... nation,s main chemicals law, the Toxic Substances Control Act ... the safety of the tens of thousands of chemicals ... conclusion of expert testimony provided at a hearing ...
Other Medicine News:Health News:Team-based diabetes care fetches more value for dollar 2Health News:Arthritis hinders physical activity for adults with heart disease 2Health News:Sauslito team wins Haagen-Dazs-Dazs-UC Davis 'Bee Friendly' garden competition 2Health News:Sauslito team wins Haagen-Dazs-Dazs-UC Davis 'Bee Friendly' garden competition 3Health News:Caffeine May Offer Some Skin Cancer Protection 2Health News:Caffeine May Offer Some Skin Cancer Protection 3Health News:Give Kids A Smile Provides Free Oral Health Care to Nearly Half-Million Children 2Health News:Main U.S. Toxics Law Failing to Ensure Safety of Thousands of Chemicals 2Health News:Main U.S. Toxics Law Failing to Ensure Safety of Thousands of Chemicals 3
... is a full-featured product capable of ... of the ophthalmic practice. This fully ... financial, administrative and clinical management needs ... as a scaleable solution, VersaVision can ...
... There is an important movement in ... access for handicapped persons. In fact, recent ... provides both. This ingenious device affords your ... your lane of equipment without having to ...
... ReSeeVit 5Z slit lamp is designed ... imaging. This video-ready slit lamp offers ... It is another addition to the ... offers the best products on the ...
... the newest and most advanced automated immunoassay ... AIA-1800 launches with a full menu of ... reproductive, cardiac, and anemia assays. ,The AIA-1800 ... primary tube sampling, auto dilution, auto pretreatment, ...
Medicine Products: